Clinical Trials for Smoking Relapse

Living with the Risk of Smoking Relapse?

Discover Hope Through Clinical Trials for Smoking Relapse in Adults

Quitting smoking is one of the most effective ways to improve health, lowering the risk of serious medical conditions both immediately and in the long term. Within minutes of quitting, heart rate and blood pressure begin to normalize as carbon monoxide levels in the blood drop to those of a nonsmoker thus significantly reducing the risk of heart disease, stroke, and cancer.

Despite these benefits, many smokers struggle with relapse. Most people quit and restart several times before they are able to remain smoke-free long term. Research shows that relapse is most likely to happen within the first few weeks of quitting, and about 75% of individuals relapse within the first six months.

Revival Research Institute is conducting clinical trials for smoking relapse to evaluate an investigational treatment that may potentially support smoking relapse prevention. These studies are designed to explore safe and effective approaches to staying smoke-free while contributing to the advancement of future treatment options.

Are You Eligible to Participate?

To participate in our clinical trial for smoking relapse study, individuals must meet the following criteria:

• Male & female between 18 to 75 years of age
• Have recently quit smoking (within the past 30 days)
• Smoked an average of ≥10 cigarettes per day

*Additional criteria may apply.

Participation in clinical trials for smoking relapse in adults in Michigan or other locations provides a chance to receive expert care, free study-related medication, and regular health monitoring by experienced medical professionals.

Get Started: What to Expect?

If you have recently quit smoking and want support to prevent relapse, you may qualify for a paid clinical trial focused on potential treatment options for this condition. After completing the interest form above, a research team member will contact you for a brief pre-screening to see if you meet the initial eligibility criteria. If you qualify, you will be asked to review and sign an Informed Consent Form (ICF), which explains all study procedures, potential benefits, and risks.

Following your consent, you’ll be invited to a screening visit at our clinical research site. During this initial visit, we will ask questions about your medical history, perform physical exams, and run lab tests to further assess your eligibility. If you meet all study requirements, you will be officially enrolled in the clinical trial.

Our team will ensure you fully understand your role in the study and what to expect throughout the process. You are encouraged to ask any questions before enrolling. Your participation will help advance new approaches in smoking relapse prevention.